These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31571451)

  • 21. Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases.
    Oliveri F; Coco B; Ciccorossi P; Colombatto P; Romagnoli V; Cherubini B; Bonino F; Brunetto MR
    World J Gastroenterol; 2008 Oct; 14(40):6154-62. PubMed ID: 18985805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B.
    Rodella A; Galli C; Terlenghi L; Perandin F; Bonfanti C; Manca N
    J Clin Virol; 2006 Nov; 37(3):206-12. PubMed ID: 16893678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV; Chrysanthos N; Hadziyannis E; Cholongitas E; Manesis EK
    J Viral Hepat; 2008 Jun; 15(6):434-41. PubMed ID: 18194171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of acute hepatitis B and reactivation of hepatitis B.
    Jindal A; Kumar M; Sarin SK
    Liver Int; 2013 Feb; 33 Suppl 1():164-75. PubMed ID: 23286861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels.
    Ormeci A; Aydın Y; Sumnu A; Baran B; Soyer OM; Pınarbasi B; Gokturk S; Gulluoglu M; Onel D; Badur S; Akyuz F; Karaca C; Demir K; Besisik F; Kaymakoglu S
    Int J Infect Dis; 2016 Nov; 52():68-73. PubMed ID: 27619844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HBV DNA and HBsAg: Early Prediction of Response to Peginterferon α-2a in HBeAg-Negative Chronic Hepatitis B.
    Zhang C; Yang Z; Wang Z; Dou X; Sheng Q; Li Y; Han C; Ding Y
    Int J Med Sci; 2020; 17(3):383-389. PubMed ID: 32132873
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of quantitative HBsAg in the natural history of e antigen-negative chronic hepatitis B: A Tunisian prospective study.
    Baklouti R; Gueddiche A; Ben Abdelwahed M; Aissaoui F; Zakhama M; Bouhlel W; Sriha A; Kooli I; Sallem OK; Argoubi A; Hichem LM; Ben Chaabane N; Safer L
    Infect Dis Now; 2021 Aug; 51(5):464-469. PubMed ID: 34366082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HBV superinfection in HCV chronic carriers: a disease that is frequently severe but associated with the eradication of HCV.
    Sagnelli E; Coppola N; Pisaturo M; Masiello A; Tonziello G; Sagnelli C; Messina V; Filippini P
    Hepatology; 2009 Apr; 49(4):1090-7. PubMed ID: 19263473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive association between serum apolipoprotein M levels and hepatitis B virus DNA load in HBeAg-negative chronic hepatitis B.
    Shen T; Wu WM; Du WH; Wang L; He G; Tan L; Wang Z; Chen R; Hu M; Ren YP
    Lipids Health Dis; 2016 Dec; 15(1):210. PubMed ID: 27927202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].
    Pei YZ; Han T; Ma XY; Li Y; Xing J; Song ZL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):743-6. PubMed ID: 22409845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Geographic distribution and characteristics of genotype A hepatitis B virus infection in acute and chronic hepatitis B patients in Japan.
    Ito K; Yotsuyanagi H; Sugiyama M; Yatsuhashi H; Karino Y; Takikawa Y; Saito T; Arase Y; Imazeki F; Kurosaki M; Umemura T; Ichida T; Toyoda H; Yoneda M; Tanaka Y; Mita E; Yamamoto K; Michitaka K; Maeshiro T; Tanuma J; Korenaga M; Murata K; Masaki N; Koike K; Mizokami M;
    J Gastroenterol Hepatol; 2016 Jan; 31(1):180-9. PubMed ID: 26110395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Correlation of hepatocyte expression of hepatitis B viral core antigen and the clinicopathological characters in chronic hepatitis B patients].
    Ding Y; Zou Z; Xu X; Zhao Z; Jia W; Fang Y; Li Y; Guo Y; Wang G
    Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):185-9. PubMed ID: 24824119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Adequacy of immediate Lamivudine trial for chronic hepatitis B patients with acute exacerbation].
    Lee CK; Suh JH; Cho YS; Won SY; Park IS
    Korean J Hepatol; 2004 Mar; 10(1):22-30. PubMed ID: 15096714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Baseline HBsAg levels associated with HBsAg loss in HBeAg-negative chronic hepatitis B infection with persistently normal alanine aminotransferase.
    Chen L; Shi J; Lu Z; Ye Y; Zhou X; Tan Y
    Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):310-316. PubMed ID: 30528063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of pegylated interferon-α2a in chronic hepatitis B patients demonstrating a spontaneous decline in HBV DNA after acute exacerbation.
    Cai Q; Chen F; Shao X; Zhang X; Zhao Z; Gao Z
    Antivir Ther; 2015; 20(2):217-24. PubMed ID: 25138110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of quantitative serum HBsAg for optimization of therapy in chronic hepatitis B patients treated with pegylated interferon alfa-2a: a Romanian cohort study.
    Gheorghiţa VI; Caruntu FA; Curescu M; Olaru I; Radu MN; Colţan G; Streinu-Cercel A
    J Gastrointestin Liver Dis; 2013 Mar; 22(1):27-32. PubMed ID: 23539387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum hepatitis B surface antigen levels correlate with high serum HBV DNA levels in patients with chronic hepatitis B: a cross-sectional study.
    Gupta E; Kumar A; Choudhary A; Kumar M; Sarin SK
    Indian J Med Microbiol; 2012; 30(2):150-4. PubMed ID: 22664428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between hepatitis B virus DNA levels and liver histology in patients with chronic hepatitis B.
    Shao J; Wei L; Wang H; Sun Y; Zhang LF; Li J; Dong JQ
    World J Gastroenterol; 2007 Apr; 13(14):2104-7. PubMed ID: 17465456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection.
    Song LW; Liu PG; Liu CJ; Zhang TY; Cheng XD; Wu HL; Yang HC; Hao XK; Yuan Q; Zhang J; Kao JH; Chen DS; Chen PJ; Xia NS
    Clin Microbiol Infect; 2015 Feb; 21(2):197-203. PubMed ID: 25658546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B.
    Le Bert N; Salimzadeh L; Gill US; Dutertre CA; Facchetti F; Tan A; Hung M; Novikov N; Lampertico P; Fletcher SP; Kennedy PTF; Bertoletti A
    J Hepatol; 2020 Jan; 72(1):34-44. PubMed ID: 31348999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.